Sequential Chemoimmunotherapy for Advanced Non-small Cell Lung Cancer Using Cisplatin, Etoposide, Thymosin- 1 and Interferon- 2a

By Garaci E.   Lopez M.   Bonsignore G.   Della Giulia M.   D'Aprile M.   Favalli C.   Rasi G.   Santini S.   Capomolla E.   Vici P.   Di Lauro L.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2403-2405

Elsevier

Access to resources Recommend Favorite

Resveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosis

By              

International Journal of Oncology, Vol. 47, Iss. 4, 2015-01 ,pp. : 1460-1468

Spandidos Publications

Access to resources Recommend Favorite

Adeno-Associated Virus Harboring Fusion Gene NT4-Ant-Shepherdin Induce Cell Death in Human Lung Cancer Cells

By Xiaojiang Tang   Jinsong Zhou   Jiansheng Wang   Chengen Pan   Guangxiao Yang   Quanying Wang  

Cancer Investigation, Vol. 28, Iss. 5, 2010-05 ,pp. : 465-471

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the Possible Protective Role of Adeno-Associated Virus Type 2 Infection in HPV-Associated Premalignant Disease of the Cervix

By Odunsi K.O.   van Ee C.C.   Ganesan T.S.   Shelling A.N.  

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 342-345

Elsevier

Access to resources Recommend Favorite

Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer

By Lokich J.   Anderson N.   Bern M.   Coco F.   Gotthardt S.   Oliynyk P.   Dow E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 659-663

Elsevier

Access to resources Recommend Favorite